Clinical Trials Browser

OTHER × Sodium-Glucose Transporter 2 Inhibitors × Thoracic × Clear all

NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

21,692 enrolled

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT07272057 2025-12-09

SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes

Phase NA Not yet recruiting

Lung Neoplasms